Concepedia

Kenneth Risner

KR

Statistics

Publications

10

Citations

292

H-Index

10

Active since

2019

Affiliations

George Mason University(Current)

Rutgers, The State University of New Jersey

Innovation Pharmaceuticals (United States)

Intelligent Synthetic Biology Center

Massachusetts Institute of Technology

Kenneth Risner is an author at George Mason University specializing in medicine, virology, and immunology.

ORCID

Top concepts

Publications per year

2019–2023

10

Publications

10

Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections

Aslaa Ahmed, Gavriella Siman-Tov, Forrest Keck et al. · Antiviral Research · 2019 · 61 citations

, , +6

Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture

Allison Bakovic, Kenneth Risner, Nishank Bhalla et al. · Viruses · 2021 · 51 citations · Full text

Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture

Kenneth Risner, Katie V. Tieu, Yafei Wang et al. · 2020 · 39 citations · Full text

Application of a Human Blood Brain Barrier Organ-on-a-Chip Model to Evaluate Small Molecule Effectiveness against Venezuelan Equine Encephalitis Virus

Niloufar A. Boghdeh, Kenneth Risner, Michael D. Barrera et al. · Viruses · 2022 · 31 citations · Full text

, , +18

Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19

Guillermo León, María Herrera, Mariángela Vargas et al. · Scientific Reports · 2021 · 29 citations · Full text

1–5 of 10